OmniSeq News

Covaris, Inc. and OmniSeq, LLC Today Announced truXTRAC™ FFPE DNA Extraction and Purification Kit as the Method of Choice for Obtaining Clinical-Grade DNA from FFPE Samples for Use with OmniSeq Target℠ Testing

WOBURN, Mass., Sept. 1, 2015 /PRNewswire/ — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused,...

read more

Follow Us on Twitter

OmniSeq is grateful for the continued support and partnership with @LABCORP . Together, we aim to expand patient access to market leading NGS diagnostics throughout the country. #NGS #TargetedTherapy #Immunotherapy #Diagnostics

https://t.co/oxmcNHLWcK

It has been 1 year since the launch of MSI-NGS. OmniSeq allows for MSI testing without the need for matched normal tissue. Let us maximize testing for this important immune oncology biomarker. We identified many MSI-H patients who could not have been tested by PCR! #AACR19

Thank you Wired Magazine and Empire State Development for featuring OmniSeq as a Western New York success story! #ngs #immunotherapy

How One NY Company Is Changing Cancer Treatment

https://t.co/4LFS221n7r

With the rapid growth of OmniSeq Advance we thought it might be time to break out an oldie but a goodie!

Load More...